There is an established relationship between DPP-4 and gut microbiota in some inflammatory diseases like IBD, where higher DPP-4 activity reduces the diversity of beneficial bacteria in favor of pathological species. This evidence concerns the gene DPP4 and irritable bowel syndrome.